{rfName}
Hy

Indexed in

License and use

Altmetrics

Analysis of institutional authors

Mitjà OCorresponding AuthorAlemany AAuthorSuñer CAuthor

Share

Publications
>
Article

Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial

Publicated to:Clinical Infectious Diseases. 73 (11): e4073-E4081 - 2021-12-06 73(11), DOI: 10.1093/cid/ciaa1009

Authors: Mitjà, O; Corbacho-Monné, M; Ubals, M; Tebé, C; Peñafiel, J; Tobias, A; Ballana, E; Alemany, A; Riera-Martí, N; Pérez, CA; Suñer, C; Laporte, P; Admella, P; Mitjà, J; Clua, M; Bertran, L; Sarquella, M; Gavilán, S; Ara, J; Argimon, JM; Casabona, J; Cuatrecasas, G; Cañadas, P; Elizalde-Torrent, A; Fabregat, R; Farré, M; Forcada, A; Flores-Mateo, G; Muntada, E; Nadal, N; Narejos, S; Nieto, A; Prat, N; Puig, J; Quiñones, C; Reyes-Ureña, J; Ramírez-Viaplana, F; Ruiz, L; Riveira-Muñoz, E; Sierra, A; Velasco, C; Vivanco-Hidalgo, RM; Sentís, A; G-Beiras, C; Clotet, B; Vall-Mayans, M

Affiliations

Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQUAS), Barcelona, Spain. - Author
Agencia Qualitat & Avaluacio Sanitaries Catalunya, Barcelona, Spain - Author
Bellvitge Biomed Res Inst IDIBELL, Lhospitalet De Llobregat, Spain - Author
Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Spain. - Author
Catalan Inst Oncol ICO, Ctr Epidemiol Studies HIV AIDS & STI Catalonia CE, Dept Salut Generalitat Catalunya, Barcelona, Spain - Author
Centre of Epidemiological Studies of HIV/AIDS and STI of Catalonia (CEEISCAT), Catalan Institute of Oncology (ICO)-Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. - Author
Centro de Investigación Biomédica en Red de Epidemiologia y Salud Pública (CIBERESP), Madrid, Spain. - Author
Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid, Spain - Author
Direcció General de Recerca i Innovació en Salut, Generalitat de Catalunya, Barcelona, Catalonia, Spain. - Author
Direcció-gerència, Institut Català de la Salut, Barcelona, Spain. - Author
Entitat Base Asociat Centelles Atencio Primaria, Centelles, Spain - Author
Entitat de Base Asociativa Centelles- Atenció Primària, Centelles, Spain. - Author
Equip Atencio Primaria Sarria, Barcelona, Spain - Author
Equip d'atenció primària de Sarria, Barcelona, Spain. - Author
Fight AIDS & Infect Dis Fdn, Badalona, Spain - Author
Fight AIDS and Infectious Diseases Foundation, Badalona, Spain. - Author
Generalitat Catalunya, Direccio Gen Recerca & Innovacio Salut, Barcelona, Spain - Author
Gerència territorial de Àmbit Metropolità nord, Institut Català de la Salut, Sabadell, Spain. - Author
Gerencia territorial de Barcelona, Institut Català de la Salut, Barcelona, Spain. - Author
Gerència territorial de Catalunya Central, Institut Català de la Salut, St Fruitós del Bages, Spain. - Author
Germans Trias & Pujol Res Inst IGTP, IrsiCaixa AIDS Res Inst, Badalona, Spain - Author
Hosp Badalona Germans Trias & Pujol, Carretera Canyet S-N, Badalona 08916, Spain - Author
Hospital Universitari Germans Trias i Pujol, Badalona, Spain. - Author
Inst Catala Salut, Direccio Gerencia, Barcelona, Spain - Author
Inst Catala Salut, Gerencia Terr Ambit Metropolita Nord, Sabadell, Spain - Author
Inst Catala Salut, Gerencia Terr Barcelona, Barcelona, Spain - Author
Inst Catala Salut, Gerencia Terr Catalunya Cent, St Fruitos Del Bages, Spain - Author
Institute of Environmental Assessment and Water Research (IDAEA), Spanish Council for Scientific Research (CSIC), Barcelona, Spain. - Author
Int SOS, Lihir Med Ctr, Lihir Isl, Guinea - Author
IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain. - Author
Lihir Medical Centre - InternationalSOS, Lihir Island, Papua New Guinea. - Author
NULL - Author
Spanish Council Sci Res CSIC, Inst Environm Assessment & Water Res IDAEA, Barcelona, Spain - Author
SYNLAB, Barcelona, Spain - Author
SYNLAB, Barcelona, Spain. - Author
Univ Autonoma Barcelona, Badalona, Spain - Author
Univ Barcelona, Fac Med, Barcelona, Spain - Author
Univ Vic, Univ Cent Catalunya UVIC UCC, Vic, Spain - Author
Universitat de Vic-Universitat Central de Catalunya (UVic-UCC), Vic, Spain. - Author
Xarxa Sanitaria & Social Santa Tecla, Tarragona, Spain - Author
Xarxa Sanitària i Social Santa Tecla, Tarragona, Spain. - Author
See more

Abstract

Keywords

covid-19randomized controlled trialsars-cov-2therapyAdultClinical trialControlled studyCovid-19Covid-19 drug treatmentDrug therapyHumanHumansHydroxychloroquineMulticenter studyRandomized controlled trialSars-cov-2TherapyTreatment outcome

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Clinical Infectious Diseases due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2021, it was in position 7/162, thus managing to position itself as a Q1 (Primer Cuartil), in the category Immunology. Notably, the journal is positioned above the 90th percentile.

This publication has been distinguished as a “Highly Cited Paper” by the agencies WoS (ESI, Clarivate) and ESI (Clarivate), meaning that it ranks within the top 1% of the most cited articles in its thematic field during the year of its publication. In terms of the observed impact of the contribution, this work is considered one of the most influential worldwide, as it is recognized as highly cited. (source consulted: ESI Nov 14, 2024)

And this is evidenced by the extremely high normalized impacts through some of the main indicators of this type, which, although dynamic over time and dependent on the set of average global citations at the time of calculation, already indicate that they are well above the average in different agencies:

  • Normalization of citations relative to the expected citation rate (ESI) by the Clarivate agency: 11.48 (source consulted: ESI Nov 14, 2024)
  • Weighted Average of Normalized Impact by the Scopus agency: 11.29 (source consulted: FECYT Feb 2024)
  • Field Citation Ratio (FCR) from Dimensions: 77.06 (source consulted: Dimensions Jun 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-06-26, the following number of citations:

  • WoS: 166
  • Scopus: 175
  • Europe PMC: 193

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-06-26:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 294.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 294 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 1520.15.
  • The number of mentions on the social network X (formerly Twitter): 1241 (Altmetric).
  • The number of mentions on Wikipedia: 3 (Altmetric).
  • The number of mentions in news outlets: 75 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.

Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: France; Guinea.

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Mitjà Villar, Oriol) .

the author responsible for correspondence tasks has been Mitjà Villar, Oriol.